Jubilant Pharma gets VAI classification from USFDA for Roorkee unit
Jubilant Pharmova, a wholly-owned subsidiary of the company, has received a communication from the US Food and Drug Administration (USFDA) that the facility has been classified as VAI pursuant to inspection from January 25 to February 2, 2024, it said in a regulatory filing.
Image Courtesy: Reuters.